Increasing hematopoietic stem cell yield to develop mice with human immune systems

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Biancotti, Juan Carlos ^a   Town, Terrence ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD34 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; NOTCH1 RECEPTOR; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA4; TRANSCRIPTION FACTOR HOXB4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WNT PROTEIN; HLA ANTIGEN;

CELL EXPANSION; CELL PROLIFERATION; CELL SURVIVAL; CULTURE MEDIUM; ENGRAFTMENT; HEMATOPOIETIC STEM CELL; IMMUNE SYSTEM; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CULTURE TECHNIQUE; CYTOLOGY; DISEASE MODEL; FETUS BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; METABOLISM; METHODOLOGY; MOUSE; PHYSIOLOGY; TRANSGENIC MOUSE; TRANSLATIONAL RESEARCH;

ANIMALS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HLA ANTIGENS; HUMANS; IMMUNE SYSTEM; MICE; MICE, TRANSGENIC; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84874870945     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/740892     Document Type: Review

References (118)

1. Appelbaum F. R., Hematopoietic-cell transplantation at 50. The New England Journal of Medicine 2007 357 15 1472 1475 2-s2.0-35248899954 10.1056/NEJMp078166 (Pubitemid 47572632)
2. Preti R. A., Lazarus H. M., Winter J., Stadtmauer E. A., Nadasi S., McMannis J., Karandish S., Jennis A., Goldberg S. L., Pecora A. L., Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer. Cytotherapy 2001 3 2 85 95 2-s2.0-17744389970 10.1080/14653240152584578 (Pubitemid 32466093)
3. Tabbara I. A., Zimmerman K., Morgan C., Nahleh Z., Allogeneic hematopoietic stem cell transplantation: complications and results. Archives of Internal Medicine 2002 162 14 1558 1566 2-s2.0-0037158107 10.1001/archinte.162. 14.1558 (Pubitemid 34765004)
4. Ferrara J. L. M., Deeg H. J., Graft-versus-host disease. The New England Journal of Medicine 1991 324 10 667 674 2-s2.0-0025963233
5. Horowitz M. M., Gale R. P., Sondel P. M., Goldman J. M., Kersey J., Kolb H. J., Rimm A. A., Ringden O., Rozman C., Speck B., Truitt R. L., Zwaan F. E., Bortin M. M., Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990 75 3 555 562 2-s2.0-0025100777 (Pubitemid 20069191)
6. Jones R. J., Ambinder R. F., Piantadosi S., Santos G. W., Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 1991 77 3 649 653 2-s2.0-0026064277
7. To L. B., Haylock D. N., Simmons P. J., Juttner C. A., The biology and clinical uses of blood stem cells. Blood 1997 89 7 2233 2258 2-s2.0-0030951437 (Pubitemid 27143269)
8. Gluckman E., Milestones in umbilical cord blood transplantation. Blood Reviews 2011 25 6 255 259 10.1016/j.blre.2011.06.003
9. Rocha V., Wagner J. E., Sobocinski K. A., Klein J. P., Zhang M. J., Horowitz M. M., Gluckman E., Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. The New England Journal of Medicine 2000 342 25 1846 1854 2-s2.0-0034702284 10.1056/NEJM200006223422501 (Pubitemid 30419048)
10. Wagner J. E., Barker J. N., DeFor T. E., Scott Baker K., Blazar B. R., Eide C., Goldman A., Kersey J., Krivit W., MacMillan M. L., Orchard P. J., Peters C., Weisdorf D. J., Ramsay N. K. C., Davies S. M., Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002 100 5 1611 1618 2-s2.0-0036721158 10.1182/blood-2002-01-0294 (Pubitemid 34925136)
11. Wagner J. E., Rosenthal J., Sweetman R., Shu X. O., Davies S. M., Ramsay N. K. C., McGlave P. B., Sender L., Cairo M. S., Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft- versus-host disease. Blood 1996 88 3 795 802 2-s2.0-0029742950 (Pubitemid 26333297)
12. Wilson A., Trumpp A., Bone-marrow haematopoietic-stem-cell niches. Nature Reviews Immunology 2006 6 2 93 106 2-s2.0-33644827383 10.1038/nri1779 (Pubitemid 43361585)
13. Ito R., Takahashi T., Katano I., Ito M., Current advances in humanized mouse models. Cellular & Molecular Immunology 2012 9 3 208 214 10.1038/cmi.2012.2
14. Shultz L. D., Brehm M. A., Garcia-Martinez J. V., Greiner D. L., Humanized mice for immune system investigation: progress, promise and challenges. Nature Reviews Immunology 2012 12 11 786 798 10.1038/nri3311
15. Shultz L. D., Ishikawa F., Greiner D. L., Humanized mice in translational biomedical research. Nature Reviews Immunology 2007 7 2 118 130 2-s2.0-33846630040 10.1038/nri2017 (Pubitemid 46174859)
16. Willinger T., Rongvaux A., Strowig T., Manz M. G., Flavell R. A., Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement. Trends in Immunology 2011 32 7 321 327 2-s2.0-79959782679 10.1016/j.it.2011.04.005
17. Shultz L. D., Schweitzer P. A., Christianson S. W., Gott B., Schweitzer I. B., Tennent B., McKenna S., Mobraaten L., Rajan T. V., Greiner D. L., Leiter E. H., Multiple defects in innate and adaptive immunologic function in NOD/LtSz- scid mice. Journal of Immunology 1995 154 1 180 191 2-s2.0-0028869986
18. + cells. Blood 2002 99 5 1620 1626 2-s2.0-0036493602 10.1182/blood.V99.5.1620 (Pubitemid 34533034)
19. + cells using the NOD/SCID/ γ cnull mice model. Blood 2003 102 3 873 880 2-s2.0-0042243661 10.1182/blood-2002-09-2755 (Pubitemid 36917778)
20. Ishikawa F., Yasukawa M., Lyons B., Yoshida S., Miyamoto T., Yoshimoto G., Watanabe T., Akashi K., Shultz L. D., Harada M., Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice. Blood 2005 106 5 1565 1573 2-s2.0-23744474685 10.1182/blood-2005-02-0516 (Pubitemid 41208567)
21. Ito M., Hiramatsu H., Kobayashi K., Suzue K., Kawahata M., Hioki K., Ueyama Y., Koyanagi Y., Sugamura K., Tsuji K., Heike T., Nakahata T., NOD/SCID/ γ cnull mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002 100 9 3175 3182 2-s2.0-18344410760 10.1182/blood-2001-12-0207 (Pubitemid 35217065)
22. Shultz L. D., Lyons B. L., Burzenski L. M., Gott B., Chen X., Chaleff S., Kotb M., Gillies S. D., King M., Mangada J., Greiner D. L., Handgretinger R., Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R γ null mice engrafted with mobilized human hemopoietic stem cells. Journal of Immunology 2005 174 10 6477 6489 2-s2.0-20844434966 (Pubitemid 40663843)
23. + cells injected into newborn RAG2-/- γ c -/- mice: functional inactivation of p53 in developing T cells. Blood 2004 104 13 3886 3893 2-s2.0-10244237695 10.1182/blood-2004-02-0656 (Pubitemid 39620134)
24. Traggiai E., Chicha L., Mazzucchelli L., Bronz L., Piffaretti J. C., Lanzavecchia A., Manz M. G., Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004 304 5667 104 107 2-s2.0-1842588698 10.1126/science.1093933 (Pubitemid 38451466)
25. Lepus C. M., Gibson T. F., Gerber S. A., Kawikova I., Szczepanik M., Hossain J., Ablamunits V., Kirkiles-Smith N., Herold K. C., Donis R. O., Bothwell A. L., Pober J. S., Harding M. J., Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/ γ c-/-, Balb/c-Rag1-/- γ c-/-, and C.B-17-scid/bg immunodeficient mice. Human Immunology 2009 70 10 790 802 2-s2.0-70349314352 10.1016/j.humimm.2009.06.005
26. Brehm M. A., Cuthbert A., Yang C., Miller D. M., DiIorio P., Laning J., Burzenski L., Gott B., Foreman O., Kavirayani A., Herlihy M., Rossini A. A., Shultz L. D., Greiner D. L., Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2r γ null mutation. Clinical Immunology 2010 135 1 84 98 2-s2.0-77649232760 10.1016/j.clim.2009.12. 008
27. Takenaka K., Prasolava T. K., Wang J. C. Y., Mortin-Toth S. M., Khalouei S., Gan O. I., Dick J. E., Danska J. S., Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nature Immunology 2007 8 12 1313 1323 2-s2.0-36248956243 10.1038/ni1527 (Pubitemid 350138972)
28. + T cell maintenance and a functional arrest of immature NK cells. Journal of Immunology 2010 185 5 2710 2720 2-s2.0-78049400478 10.4049/jimmunol.1000583
29. Watanabe S., Terashima K., Ohta S., Horibata S., Yajima M., Shiozawa Y., Zahidunnabi Dewan M., Yu Z., Ito M., Morio T., Shimizu N., Honda M., Yamamoto N., Hematopoietic stem cell-engrafted NOD/SCID/IL2R γ null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 2007 109 1 212 218 2-s2.0-33846104485 10.1182/blood-2006-04-017681 (Pubitemid 46070123)
30. Huntington N. D., Alves N. L., Legrand N., Lim A., Strick-Marchand H., Mention J. J., Pletf A., Weijer K., Jacques Y., Becker P. D., Guzman C., Soussan P., Kremsdorf D., Spits H., Di Santo J. P., IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo. Proceedings of the National Academy of Sciences of the United States of America 2011 108 15 6217 6222 2-s2.0-79955010744 10.1073/pnas.1019167108
31. van Lent A. U., Dontje W., Nagasawa M., Siamari R., Bakker A. Q., Pouw S. M., Maijoor K. A., Weijer K., Cornelissen J. J., Blom B., Di Santo J. P., Spits H., Legrand N., IL-7 enhances thymic human T cell development in «human immune system» Rag2-/-IL-2R γ c-/- mice without affecting peripheral T cell homeostasis. Journal of Immunology 2009 183 12 7645 7655 2-s2.0-76249133496 10.4049/jimmunol.0902019
32. Schmidt M. R., Appel M. C., Giassi L. J., Greiner D. L., Shultz L. D., Woodland R. T., Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice. PLoS One 2008 3 9, article e3192 2-s2.0-52649106011 10.1371/journal.pone.0003192
33. Chen Q., Khoury M., Chen J., Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proceedings of the National Academy of Sciences of the United States of America 2009 106 51 21783 21788 2-s2.0-76049092600 10.1073/pnas.0912274106
34. O'Connell R. M., Balazs A. B., Rao D. S., Kivork C., Yang L., Baltimore D., Lentiviral vector delivery of human interleukin-7 (hiL-7) to human immune system (HIS) mice expands T lymphocyte populations. PLoS One 2010 5 8, article e12009 2-s2.0-77957773125 10.1371/journal.pone.0012009
35. + regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2R γ null humanized mice. Blood 2011 117 11 3076 3086 2-s2.0-79953076702 10.1182/blood-2010-08-301507
36. Nicolini F. E., Cashman J. D., Hogge D. E., Humphries R. K., Eaves C. J., NOD/SCID mice engineered to express human IL-3, GM-CSF and steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration. Leukemia 2004 18 2 341 347 2-s2.0-1242329864 10.1038/sj.leu.2403222 (Pubitemid 38240052)
37. Takagi S., Saito Y., Hijikata A., Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation. Blood 2012 119 12 2768 2777 10.1182/blood-2011-05-353201
38. Brehm M. A., Racki W. J., Leif J., Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2rgamma null mice is enhanced by transgenic expression of membrane-bound human SCF. Blood 2012 119 12 2778 2788 10.1182/blood-2011-05-353243
39. Rongvaux A., Willinger T., Takizawa H., Rathinam C., Auerbach W., Murphy A. J., Valenzuela D. M., Yancopoulos G. D., Eynon E. E., Stevens S., Manz M. G., Flavell R. A., Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. Proceedings of the National Academy of Sciences of the United States of America 2011 108 6 2378 2383 2-s2.0-79952294749 10.1073/pnas.1019524108
40. Rathinam C., Poueymirou W. T., Rojas J., Efficient differentiation and function of human macrophages in humanized CSF-1 mice. Blood 2011 118 11 3119 3128 10.1182/blood-2010-12-326926
41. Willinger T., Rongvaux A., Takizawa H., Yancopoulos G. D., Valenzuela D. M., Murphy A. J., Auerbach W., Eynon E. E., Stevens S., Manz M. G., Flavell R. A., Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proceedings of the National Academy of Sciences of the United States of America 2011 108 6 2390 2395 2-s2.0-79952304617 10.1073/pnas.1019682108
42. Legrand N., Weijer K., Spits H., Experimental models to study development and function of the human immune system in vivo. Journal of Immunology 2006 176 4 2053 2058 2-s2.0-32044454701 (Pubitemid 43201649)
43. Becker P. D., Legrand N., van Geelen C. M. M., Noerder M., Huntington N. D., Lim A., Yasuda E., Diehl S. A., Scheeren F. A., Ott M., Weijer K., Wedemeyer H., di Santo J. P., Beaumont T., Guzman C. A., Spits H., Generation of human antigen-specific monoclonal IgM antibodies using vaccinated «human immune system» mice. PLoS One 2010 5 10, article e13137 2-s2.0-78049251370 10.1371/journal.pone.0013137
44. Kametani Y., Shiina M., Katano I., Ito R., Ando K., Toyama K., Tsukamoto H., Matsumura T., Saito Y., Ishikawa D., Taki T., Ito M., Imai K., Tokuda Y., Kato S., Tamaoki N., Habu S., Development of human-human hybridoma from anti-Her-2 peptide-producing B cells in immunized NOG mouse. Experimental Hematology 2006 34 9 1240 1248 2-s2.0-33750618431
45. Watanabe Y., Takahashi T., Okajima A., Shiokawa M., Ishii N., Katano I., Ito R., Ito M., Minegishi M., Minegishi N., Tsuchiya S., Sugamura K., The analysis of the functions of human B and T cells in humanized NOD/shi-scid/ γ cnull (NOG) mice (hu-HSC NOG mice). International Immunology 2009 21 7 843 858 2-s2.0-67649838584 10.1093/intimm/dxp050
46. + cord blood cell-transplanted Rag2-/- γ c-/- mice. Proceedings of the National Academy of Sciences of the United States of America 2006 103 43 15951 15956 2-s2.0-33750436225 10.1073/pnas.0604493103 (Pubitemid 44657573)
47. Fairfax K. A., Kallies A., Nutt S. L., Tarlinton D. M., Plasma cell development: from B-cell subsets to long-term survival niches. Seminars in Immunology 2008 20 1 49 58 2-s2.0-39649084660 10.1016/j.smim.2007.12.002
48. Takahama Y., Nitta T., Mat Ripen A., Nitta S., Murata S., Tanaka K., Role of thymic cortex-specific self-peptides in positive selection of T cells. Seminars in Immunology 2010 22 5 287 293 2-s2.0-77955985022 10.1016/j.smim.2010. 04.012
49. + cell transplantation. Blood 2006 108 2 487 492 2-s2.0-33745959565 10.1182/blood-2005-11-4388 (Pubitemid 44061346)
50. Rajesh D., Zhou Y., Jankowska-Gan E., Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgammanull mice. Human Immunology 2010 71 6 551 559 10.1016/j.humimm.2010.02.019
51. Covassin L., Laning J., Abdi R., Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rgamma(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease. Clinical & Experimental Immunology 2011 166 2 269 280 10.1111/j.1365-2249.2011.04462.x
52. Danner R., Chaudhari S. N., Rosenberger J., Surls J., Richie T. L., Brumeanu T. D., Casares S., Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS One 2011 6 5, article e19826 2-s2.0-79956073079 10.1371/journal.pone.0019826
53. + T Cells in HLA-B51:01 transgenic humanized mice after infection with HIV-1. PLoS One 2012 7 8, article e42776
54. Suzuki M., Takahashi T., Katano I., Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/gammacnull mouse. International Immunology 2012 24 4 243 252
55. Jaiswal S., Pearson T., Friberg H., Shultz L. D., Greiner D. L., Rothman A. L., Mathew A., Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2r γ null mice. PLoS One 2009 4 10, article e7251 2-s2.0-70350031633 10.1371/journal.pone.0007251
56. Shultz L. D., Saito Y., Najima Y., Tanaka S., Ochi T., Tomizawa M., Doi T., Sone A., Suzuki N., Fujiwara H., Yasukawa M., Ishikawa F., Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r γ null humanized mice. Proceedings of the National Academy of Sciences of the United States of America 2010 107 29 13022 13027 2-s2.0-77955599615 10.1073/pnas.1000475107
57. Strowig T., Gurer C., Ploss A., Liu Y. F., Arrey F., Sashihara J., Koo G., Rice C. M., Young J. W., Chadburn A., Cohen J. I., Münz C., Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. Journal of Experimental Medicine 2009 206 6 1423 1434 2-s2.0-67449168401 10.1084/jem.20081720
58. Takizawa H., Schanz U., Manz M. G., Ex vivo expansion of hematopoietic stem cells: mission accomplished? Swiss Medical Weekly 2011 141, article w13316 10.4414/smw.2011.13316
59. Yonemura Y., Ku H., Lyman S. D., Ogawa M., In vitro expansion of hematopoietic progenitors and maintenance of stem cells: comparison between FLT3/FLK-2 ligand and KIT ligand. Blood 1997 89 6 1915 1921 2-s2.0-0030899608 (Pubitemid 27132105)
60. Nakauchi H., Sudo K., Ema H., Quantitative assessment of the stem cell self-renewal capacity. Annals of the New York Academy of Sciences 2001 938 18 25 2-s2.0-0034943707 (Pubitemid 32620014)
61. Yagi M., Ritchie K. A., Sitnicka E., Storey C., Roth G. J., Bartelmez S., Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin. Proceedings of the National Academy of Sciences of the United States of America 1999 96 14 8126 8131 2-s2.0-0033529218 10.1073/pnas.96.14.8126 (Pubitemid 29328419)
62. Hoffman R., Tong J., Brandt J., Traycoff C., Bruno E., McGuire B. W., Gordon M. S., McNiece I., Srour E. F., The in vitro and in vivo effects of stem cell factor on human hematopoiesis. Stem Cells 1993 11 supplement 2 76 82 2-s2.0-0027442795 (Pubitemid 23331557)
63. Piacibello W., Sanavio F., Garetto L., Severino A., Danè A., Gammaitoni L., Aglietta M., The role of c-Mpl ligands in the expansion of cord blood hematopoietic progenitors. Stem Cells 1998 16 supplement 2 243 248 2-s2.0-0032227537
64. Bryder D., Jacobsen S. E. W., Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood 2000 96 5 1748 1755 2-s2.0-0034283746 (Pubitemid 30661058)
65. + cells from umbilical cord blood. Stem Cells and Development 2010 19 3 413 422 2-s2.0-77949619008 10.1089/scd.2009.0098
66. Roßmanith T., Schröder B., Bug G., Müller P., Klenner T., Knaus R., Hoelzer D., Ottmann O. G., Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of SCID repopulating cells. Stem Cells 2001 19 4 313 320 2-s2.0-17144458731 (Pubitemid 32721098)
67. Varnum-Finney B., Brashem-Stein C., Bernstein I. D., Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. Blood 2003 101 5 1784 1789 2-s2.0-0037370834 10.1182/blood-2002-06-1862 (Pubitemid 36237574)
68. Lemieux M. E., Chappel S. M., Miller C. L., Eaves C. J., Differential ability of flt3-ligand, interleukin-11, and steel factor to support the generation of B cell progenitors and myeloid cells from primitive murine fetal liver cells. Experimental Hematology 1997 25 9 951 957 2-s2.0-0030748924 (Pubitemid 27368286)
69. + cell population from cord blood vs. adult bone marrow. Experimental Hematology 1995 23 12 1289 1295 2-s2.0-0028807712
70. - bone marrow cells. Experimental Hematology 2007 35 12 1872 1883 2-s2.0-36148993920 10.1016/j.exphem.2007.08.007 (Pubitemid 350117114)
71. Ottmann O. G., Abboud M., Welte K., Souza L. M., Pelus L. M., Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors. Experimental Hematology 1989 17 2 191 197 2-s2.0-0024538071 (Pubitemid 19056047)
72. Saeland S., Caux C., Favre C., Aubry J. P., Mannoni P., Pebusque M. J., Gentilhomme O., Otsuka T., Yokota T., Arai N., Arai K., Banchereau J., De Vries J. E., Effects of recombinant human interleukin-3 on CD34-enriched normal hematopoietic progenitors and on myeloblastic leukemia cells. Blood 1988 72 5 1580 1588 2-s2.0-0023794340 (Pubitemid 18268638)
73. + cells from cord blood. Haematologica 2003 88 4 388 395 2-s2.0-0038712206 (Pubitemid 36547124)
74. Piacibello W., Gammaitoni L., Bruno S., Gunetti M., Fagioli F., Cavalloni G., Aglietta M., Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells. Journal of Hematotherapy and Stem Cell Research 2000 9 6 945 956 2-s2.0-0034488186 10.1089/152581600750062408 (Pubitemid 32110296)
75. low/neg human bone marrow cells. Blood 1999 94 2 529 538 2-s2.0-0033566322 (Pubitemid 29323867)
76. Himburg H. A., Muramoto G. G., Daher P., Meadows S. K., Russell J. L., Doan P., Chi J. T., Salter A. B., Lento W. E., Reya T., Chao N. J., Chute J. P., Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells. Nature Medicine 2010 16 4 475 482 2-s2.0-77950543499 10.1038/nm.2119
77. Kojika S., Griffin J. D., Notch receptors and hematopoiesis. Experimental Hematology 2001 29 9 1041 1052 2-s2.0-0034876802 10.1016/S0301-472X(01)00676-2 (Pubitemid 32782638)
78. Dallas M. H., Varnum-Finney B., Martin P. J., Bernstein I. D., Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1. Blood 2007 109 8 3579 3587 2-s2.0-34147120233 10.1182/blood-2006-08-039842 (Pubitemid 46572553)
79. Delaney C., Heimfeld S., Brashem-Stein C., Voorhies H., Manger R. L., Bernstein I. D., Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nature Medicine 2010 16 2 232 236 2-s2.0-76349113345 10.1038/nm.2080
80. - cord blood cells. Journal of Clinical Investigation 2002 110 8 1165 1174 2-s2.0-0036802174 10.1172/JCI200216167 (Pubitemid 35215897)
81. Delaney C., Varnum-Finney B., Aoyama K., Brashem-Stein C., Bernstein I. D., Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. Blood 2005 106 8 2693 2699 2-s2.0-27144518462 10.1182/blood-2005-03-1131 (Pubitemid 41510742)
82. Zhang C. C., Kaba M., Ge G., Xie K., Tong W., Hug C., Lodish H. F., Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nature Medicine 2006 12 2 240 245 2-s2.0-32244436673 10.1038/nm1342 (Pubitemid 43214753)
83. Zhang C. C., Kaba M., Lizuka S., Huynh H., Lodish H. F., Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/sCiD transplantation. Blood 2008 111 7 3415 3423 2-s2.0-43549113659 10.1182/blood-2007-11-122119
84. Bhardwaj G., Murdoch B., Wu D., Baker D. P., Williams K. P., Chadwick K., Ling L. E., Karanu F. N., Bhatia M., Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nature Immunology 2001 2 2 172 180 2-s2.0-0035257660 10.1038/84282 (Pubitemid 33707938)
85. Trowbridge J. J., Scott M. P., Bhatia M., Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration. Proceedings of the National Academy of Sciences of the United States of America 2006 103 38 14134 14139 2-s2.0-33749000855 10.1073/pnas.0604568103 (Pubitemid 44452992)
86. Gao J., Graves S., Koch U., Liu S., Jankovic V., Buonamici S., El Andaloussi A., Nimer S. D., Kee B. L., Taichman R., Radtke F., Aifantis I., Hedgehog signaling is dispensable for adult hematopoietic stem cell function. Cell Stem Cell 2009 4 6 548 558 2-s2.0-66049102512 10.1016/j.stem.2009.03.015
87. Hofmann I., Stover E. H., Cullen D. E., Mao J., Morgan K. J., Lee B. H., Kharas M. G., Miller P. G., Cornejo M. G., Okabe R., Armstrong S. A., Ghilardi N., Gould S., de Sauvage F. J., McMahon A. P., Gilliland D. G., Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell 2009 4 6 559 567 2-s2.0-66049085125 10.1016/j.stem.2009.03.016
88. Wada T., Penninger J. M., Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004 23 16 2838 2849 2-s2.0-2342562556 10.1038/sj.onc. 1207556 (Pubitemid 38638846)
89. Zarubin T., Han J., Activation and signaling of the p38 MAP kinase pathway. Cell Research 2005 15 1 11 18 2-s2.0-19644367000 10.1038/sj.cr.7290257 (Pubitemid 41653958)
90. Wang Y., Kellner J., Liu L., Zhou D., Inhibition of p38 mitogen-activated protein kinase promotes ex vivo hematopoietic stem cell expansion. Stem Cells and Development 2011 20 7 1143 1152 2-s2.0-79959818068 10.1089/scd.2010.0413
91. Zou J., Zou P., Wang J., Inhibition of p38 MAPK activity promotes ex vivo expansion of human cord blood hematopoietic stem cells. Annals of Hematology 2012 91 6 813 823 10.1007/s00277-011-1397-7
92. Bug G., Gül H., Schwarz K., Pfeifer H., Kampfmann M., Zheng X., Beissert T., Boehrer S., Hoelzer D., Ottmann O. G., Ruthardt M., Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Research 2005 65 7 2537 2541 2-s2.0-20144388533 10.1158/0008-5472.CAN-04-3011 (Pubitemid 40490047)
93. North T. E., Goessling W., Walkley C. R., Lengerke C., Kopani K. R., Lord A. M., Weber G. J., Bowman T. V., Jang I. H., Grosser T., Fitzgerald G. A., Daley G. Q., Orkin S. H., Zon L. I., Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007 447 7147 1007 1011 2-s2.0-34250883337 10.1038/nature05883 (Pubitemid 46975751)
94. Hoggatt J., Singh P., Sampath J., Pelus L. M., Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 2009 113 22 5444 5455 2-s2.0-67049134758 10.1182/blood-2009-01-201335
95. Goessling W., North T. E., Loewer S., Lord A. M., Lee S., Stoick-Cooper C. L., Weidinger G., Puder M., Daley G. Q., Moon R. T., Zon L. I., Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009 136 6 1136 1147 2-s2.0-62149148156 10.1016/j.cell.2009.01.015
96. Boitano A. E., Wang J., Romeo R., Bouchez L. C., Parker A. E., Sutton S. E., Walker J. R., Flaveny C. A., Perdew G. H., Denison M. S., Schultz P. G., Cooke M. P., Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010 329 5997 1345 1348 2-s2.0-77956519710 10.1126/science.1191536
97. Antonchuk J., Sauvageau G., Humphries R. K., HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 2002 109 1 39 45 2-s2.0-0037023528 10.1016/S0092-8674(02)00697-9 (Pubitemid 34327515)
98. Fournier M., Lebert-Ghali C. É., Krosl G., Bijl J. J., HOXA4 induces expansion of hematopoietic stem cells in vitro and confers enhancement of pro-B-cells in vivo. Stem Cells and Development 2012 21 1 133 142 10.1089/scd.2011.0259
99. Miyake N., Brun A. C. M., Magnusson M., Miyake K., Scadden D. T., Karlsson S., HOXB4-induced self-renewal of hematopoietic stem cells is significantly enhanced by p21 deficiency. Stem Cells 2006 24 3 653 661 2-s2.0-33744996081 10.1634/stemcells.2005-0328 (Pubitemid 44464769)
100. Amsellem S., Pflumio F., Bardinet D., Izac B., Charneau P., Romeo P. H., Dubart-Kupperschmitt A., Fichelson S., Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nature Medicine 2003 9 11 1423 1427 2-s2.0-0345708270 10.1038/nm953 (Pubitemid 37466194)
101. + hematopoietic cells ectopically expressing HOXB4. Growth Factors 2006 24 2 97 105 2-s2.0-33745520404 10.1080/08977190600581269 (Pubitemid 43977100)
102. Auvray C., Delahaye A., Pflumio F., HOXC4 homeoprotein efficiently expands human hematopoietic stem cells and triggers similar molecular alterations as HOXB4. Haematologica 2012 97 2 168 178 10.3324/haematol.2011. 051235
103. Reya T., Duncan A. W., Ailles L., Domen J., Scherer D. C., Willert K., Hintz L., Nusse R., Weissman I. L., A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003 423 6938 409 414 2-s2.0-0037737728 10.1038/nature01593 (Pubitemid 36626987)
104. Willert K., Brown J. D., Danenberg E., Duncan A. W., Weissman I. L., Reya T., Yates J. R., Nusse R., Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003 423 6938 448 452 2-s2.0-0037737726 10.1038/nature01611 (Pubitemid 36626997)
105. Kirstetter P., Anderson K., Porse B. T., Jacobsen S. E. W., Nerlov C., Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nature Immunology 2006 7 10 1048 1056 2-s2.0-33748850636 10.1038/ni1381 (Pubitemid 44420649)
106. Scheller M., Huelsken J., Rosenbauer F., Taketo M. M., Birchmeier W., Tenen D. G., Leutz A., Hematopoietic stem cell and multilineage defects generated by constitutive β -catenin activation. Nature Immunology 2006 7 10 1037 1047 2-s2.0-33748859509 10.1038/ni1387 (Pubitemid 44420648)
107. Cobas M., Wilson A., Ernst B., Mancini S. J. C., MacDonald H. R., Kemler R., Radtke F., β -catenin is dispensable for hematopoiesis and lymphopoiesis. Journal of Experimental Medicine 2004 199 2 221 229 2-s2.0-1642499734 10.1084/jem.20031615 (Pubitemid 38129702)
108. Koch U., Wilson A., Cobas M., Kemler R., MacDonald H. R., Radtke F., Simultaneous loss of β-and γ -catenin does not perturb hematopoiesis or lymphopoiesis. Blood 2008 111 1 160 164 2-s2.0-38049139201 10.1182/blood-2007-07-099754
109. Murdoch B., Chadwick K., Martin M., Shojaei F., Shah K. V., Gallacher L., Moon R. T., Bhatia M., Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo. Proceedings of the National Academy of Sciences of the United States of America 2003 100 6 3422 3427 2-s2.0-0037452998 10.1073/pnas.0130233100 (Pubitemid 36356599)
110. Trowbridge J. J., Xenocostas A., Moon R. T., Bhatia M., Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. Nature Medicine 2006 12 1 89 98 2-s2.0-30044444251 10.1038/nm1339 (Pubitemid 43050082)
111. + progenitors. Experimental Hematology 1995 23 6 551 556 2-s2.0-0029035978
112. Fortunel N. O., Hatzfeld A., Hatzfeld J. A., Transforming growth factor- β pleiotropic role in the regulation of hematopoiesis. Blood 2000 96 6 2022 2036 2-s2.0-0034665777
113. Zhang Y., Harada A., Bluethmann H., Wang J. B., Nakao S., Mukaida N., Matsushima K., Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF α in vitro. Blood 1995 86 8 2930 2937 2-s2.0-0028841183
114. Broxmeyer H. E., Kim C. H., Regulation of hematopoiesis in a sea of
115. Cashman J. D., Eaves C. J., Sarris A. H., Eaves A. C., MCP-1, not MIP-1 α is the endogenous chemokine that cooperates with TGF- β to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures. Blood 1998 92 7 2338 2344 2-s2.0-0032190067 (Pubitemid 28452975)
116. Kirouac D. C., Ito C., Csaszar E., Dynamic interaction networks in a hierarchically organized tissue. Molecular Systems Biology 2010 6, article 417 10.1038/msb.2010.71
117. + cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001 97 10 3075 3085 2-s2.0-0035874498 10.1182/blood.V97.10.3075
118. Csaszar E., Kirouac D. C., Yu M., Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling. Cell Stem Cell 2012 10 2 218 229 10.1016/j.stem.2012.01.003